Compare · BBNX vs MDLN
BBNX vs MDLN
Side-by-side comparison of Beta Bionics Inc. (BBNX) and Medline Inc. (MDLN): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both BBNX and MDLN operate in Medical/Dental Instruments (Health Care), so they compete in similar markets.
- MDLN is the larger of the two at $46.86B, about 53.9x BBNX ($870.1M).
- Over the past year, BBNX is up 4.7% and MDLN is down 13.4% - BBNX leads by 18.1 points.
- MDLN has been more active in the news (12 items in the past 4 weeks vs 2 for BBNX).
- MDLN has more recent analyst coverage (25 ratings vs 18 for BBNX).
PerformanceBBNX-34.26%MDLN-13.37%
2025-12-17+0.00%2026-08-26
- Company
- Beta Bionics Inc.
- Medline Inc.
- Price
- $19.19-0.72%
- $35.30-0.94%
- Market cap
- $870.1M
- $46.86B
- 1M return
- +21.38%
- -12.86%
- 1Y return
- +4.69%
- -13.37%
- Industry
- Medical/Dental Instruments
- Medical/Dental Instruments
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2025
- 2025
- News (4w)
- 2
- 12
- Recent ratings
- 18
- 25
Latest BBNX
- William Blair initiated coverage on Beta Bionics
- Amendment: SEC Form SCHEDULE 13G/A filed by Beta Bionics Inc.
- SEC Form 10-Q filed by Beta Bionics Inc.
- Beta Bionics Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Beta Bionics Announces Second Quarter 2026 Financial Results and Updates Full Year 2026 Guidance
- UBS resumed coverage on Beta Bionics with a new price target
- Amendment: Chief Financial Officer Feider Stephen exercised 10,000 shares at a strike of $5.10 and sold $170,387 worth of shares (10,000 units at $17.04) as part of a pre-agreed trading plan (SEC Form 4)
- Beta Bionics to Announce Second Quarter 2026 Financial Results on July 29, 2026
- Chief Financial Officer Feider Stephen exercised 9,878 shares at a strike of $5.10 and sold $170,387 worth of shares (10,000 units at $17.04) as part of a pre-agreed trading plan, decreasing direct ownership by 0.07% to 165,931 units (SEC Form 4)
- Chief Commercial Officer Hopman Mark sold $18,880 worth of shares (1,258 units at $15.01) as part of a pre-agreed trading plan, decreasing direct ownership by 0.96% to 129,354 units (SEC Form 4)
Latest MDLN
- SEC Form 4 filed by Chief Executive Officer Boyle James M
- SEC Form 4 filed by Chief Operating Officer Miller Stephen L
- Large owner Gic Private Ltd sold $57,280,000 worth of shares (1,600,000 units at $35.80) (SEC Form 4)
- Amendment: SEC Form SCHEDULE 13G/A filed by Medline Inc.
- Large owner Gic Private Ltd sold $21,002,305 worth of shares (590,284 units at $35.58) (SEC Form 4)
- Large owner Mozart Holdco, Inc. converted options into 500,000 shares and disposed of 500,000 units of Class B Common Stock, increasing direct ownership by 81,083% to 233,520,656 units (SEC Form 4)
- Amendment: SEC Form SCHEDULE 13G/A filed by Medline Inc.
- Large owner Gic Private Ltd sold $79,971,448 worth of shares (2,248,612 units at $35.56) (SEC Form 4)
- SEC Form SCHEDULE 13G filed by Medline Inc.
- SEC Form 10-Q filed by Medline Inc.